Preparation of ginsenoside compound-K mixed micelles with improved retention and antitumor efficacy

Reference

• YosiokaISugawaraTImaiKKitagawaISoil bacterial hydrolysis leading to genuine aglycone. V. On ginsenosides Rbl, Rb2 and Rc of the ginseng root saponinsChem Pharm Bull (Tokyo)1972201124182421
   Web of Science ®Google Scholar
• HasegawaHSungJHMatsumiyaSUchiyamaMMain ginseng saponin metabolites formed by intestinal bacteriaPlanta Med19966254534578923812
   PubMed Web of Science ®Google Scholar
• AkaoTKidaHKanaokaMHattoriMKobashiKIntestinal bacterial hydrolysis is required for the appearance of compound K in rat plasma after oral administration of ginsenoside Rb1 from Panax ginsengJ Pharm Pharmacol19985010115511609821663
   PubMed Web of Science ®Google Scholar
• ManSGaoWZhangYHuangLLiuCChemical study and medical application of saponins as anti-cancer agentsFitoterapia201081770371420550961
   PubMed Web of Science ®Google Scholar
• QiLWWangCZYuanCSGinsenosides from American ginseng: chemical and pharmacological diversityPhytochemistry201172868969921396670
   PubMed Web of Science ®Google Scholar
• YuHZhangCLuMSunFFuYJinFPurification and characterization of new special ginsenosidase hydrolyzing multi-glycisides of protopanaxadiol ginsenosides, ginsenosidase type IChem Pharm Bull (Tokyo)200755223123517268094
   PubMed Web of Science ®Google Scholar
• KangKAKimYWKimSUG1 phase arrest of the cell cycle by a ginseng metabolite, compound K, in U937 human monocytic leukamia cellsArch Pharm Res200528668569016042078
   PubMed Web of Science ®Google Scholar
• ZhangZDuGJWangCZCompound K, a ginsenoside metabolite, inhibits colon cancer growth via multiple pathways including p53–p21 interactionsInt J Mol Sci20131422980299523434653
   PubMed Web of Science ®Google Scholar
• LeeSJKoWGKimJHSungJHMoonCKLeeBHInduction of apop-tosis by a novel intestinal metabolite of ginseng saponin via cytochrome c-mediated activation of caspase-3 proteaseBiochem Pharmacol200060567768510927026
   PubMed Web of Science ®Google Scholar
• ChoSHChungKSChoiJHKimDHLeeKTCompound K, a metabolite of ginseng saponin, induces apoptosis via caspase-8-dependent pathway in HL-60 human leukemia cellsBMC Cancer2009944920017956
   PubMed Web of Science ®Google Scholar
• MingYChenZChenLGinsenoside compound K attenuates metastatic growth of hepatocellular carcinoma, which is associated with the translocation of nuclear factor-kB p65 and reduction of matrix metalloproteinase-2/9Planta Med201177542843320979019
   PubMed Web of Science ®Google Scholar
• YangZWangJRNiuTInhibition of P-glycoprotein leads to improved oral bioavailability of compound K, an anticancer metabolite of red ginseng extract produced by gut microfloraDrug Metab Dispos20124081538154422584255
   PubMed Web of Science ®Google Scholar
• PaekIBMoonYKimJPharmacokinetics of a ginseng saponin metabolite compound K in ratsBiopharm Drug Dispos2006271394516302287
   PubMed Web of Science ®Google Scholar
• LeePSSongTWSungJHMoonDCSongSChungYBPharmacoki-netic characteristics and hepatic distribution of IH-901, a novel intestinal metabolite of ginseng saponin, in ratsPlanta Med200672320421016534723
   PubMed Web of Science ®Google Scholar
• JiangTZhangZZhangYDual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug deliveryBiomaterials201233369246925823031530
   PubMed Web of Science ®Google Scholar
• ZhangZChenYDengJJiaXZhouJLvHSolid dispersion of berberine-phospholipid complex/TPGS 1000/SiO2: preparation, characterization and in vivo studiesInt J Pharm20144651–230631624456672
   PubMed Web of Science ®Google Scholar
• WangWLiMZhangZDesign, synthesis and evaluation of multi-functional tLyP-1-hyaluronic acid-paclitaxel conjugate endowed with broad anticancer scopeCarbohydr Polym20171569710727842858
   PubMed Web of Science ®Google Scholar
• MathiyalaganRSubramaniyamSKimYJSynthesis and pharmacokinetic characterization of a pH-sensitive polyethylene glycol ginsenoside CK (PEG-CK) conjugateBiosci Biotechnol Biochem201478346646825036835
   PubMed Web of Science ®Google Scholar
• MathiyalaganRSubramaniyamSKimYJKimYCYangDCGinsenoside compound K-bearing glycol chitosan conjugates: synthesis, physicochemical characterization, and in vitro biological studiesCarbohydr Polym201411235936625129755
   PubMed Web of Science ®Google Scholar
• YangLXinJZhangZTPGS-modified liposomes for the delivery of ginsenoside compound K against non-small cell lung cancer: formulation design and its evaluation in vitro and in vivoJ Pharm Pharmacol20166891109111827368109
   PubMed Web of Science ®Google Scholar
• ZhangYTongDCheDAscorbyl palmitate/d-α-tocopheryl polyethylene glycol 1000 succinate monoester mixed micelles for prolonged circulation and targeted delivery of compound K for antilung cancer therapy in vitro and in vivoInt J Nanomedicine20171260561428144142
   PubMed Web of Science ®Google Scholar
• MohamedEAAbu HashimIIYusifRMPolymeric micelles for potentiated antiulcer and anticancer activities of naringinInt J Nanomedicine2018131009102729497294
   PubMed Web of Science ®Google Scholar
• LinJZhaoCLiuCRedox-responsive F127-folate/F127-disulfide bond-d-α-tocopheryl polyethylene glycol 1000 succinate/P123 mixed micelles loaded with paclitaxel for the reversal of multidrug resistance in tumorsInt J Nanomedicine20181380583029445276
   PubMed Web of Science ®Google Scholar
• JinXZhangYZhangZCheDLvHJuglone loaded poloxamer 188/phospholipid mixed micelles evaluated in vitro and in vivo in breast cancerInt J Pharm20165151–235936627744033
   PubMedGoogle Scholar
• DuanYZhangBChuLTongHHLiuWZhaiGEvaluation in vitro and in vivo of curcumin-loaded mPEG-PLA/TPGS mixed micelles for oral administrationColloids Surf B Biointerfaces201614134535426874910
   PubMed Web of Science ®Google Scholar
• GaoZGFainHDRapoportNControlled and targeted tumor chemotherapy by micellar-encapsulated drug and ultrasoundJ Control Release2005102120322215653146
   PubMed Web of Science ®Google Scholar
• DongJSongXLianXFuYGongTSubcutaneously injected ivermectin-loaded mixed micelles: formulation, pharmacokinetics and local irritation studyDrug Deliv20162372220222725188004
   PubMed Web of Science ®Google Scholar
• GillKKKaddoumiANazzalSPEG-lipid micelles as drug carriers: physiochemical attributes, formulation principles and biological implicationJ Drug Target201523322223125547369
   PubMed Web of Science ®Google Scholar
• CheJOkekeCIHuZBXuJDSPE-PEG: a distinctive component in drug delivery systemCurr Pharm Des201521121598160525594410
   PubMed Web of Science ®Google Scholar
• YangCWuTQinYA facile doxorubicin-dichloroacetate conjugate nanomedicine with high drug loading for safe drug deliveryInt J Nanomedicine2018131281129329563787
   PubMed Web of Science ®Google Scholar
• HaghiralsadatFAmoabedinyGHelderMNA comprehensive mathematical model of drug release kinetics from nano-liposomes, derived from optimization studies of cationic PEGylated liposomal doxorubicin formulations for drug-gene deliveryArtif Cells Nanomed Biotechnol201846116917728376641
   PubMed Web of Science ®Google Scholar
• RydbergHAYanez ArtetaMBergSLindforsLSigfridssonKProbing adsorption of DSPE-PEG2000 and DSPE-PEG5000 to the surface of felodipine and griseofulvin nanocrystalsInt J Pharm2016510123223927329674
   PubMedGoogle Scholar
• JinYZhangZZhaoTLiuXJianLMixed micelles of doxorubicin overcome multidrug resistance by inhibiting the expression of P-glycoproteinJ Biomed Nanotechnol20151181330133826295136
   PubMed Web of Science ®Google Scholar
• BaeYHParkKTargeted drug delivery to tumors: myths, reality and possibilityJ Control Release2011153319820521663778
   PubMed Web of Science ®Google Scholar
• TorchilinVTumor delivery of macromolecular drugs based on the EPR effectAdv Drug Deliv Rev201163313113520304019
   PubMed Web of Science ®Google Scholar
• ZhangYRenTGouJStrategies for improving the payload of small molecular drugs in polymeric micellesJ Control Release201726135236628163211
   PubMed Web of Science ®Google Scholar
• ManaiaEBAbuçafyMPChiari-AndréoBGSilvaBLOshiro JuniorJAChiavacciLAPhysicochemical characterization of drug nanocarriersInt J Nanomedicine2017124991501128761340
   PubMed Web of Science ®Google Scholar
• DeshmukhASChauhanPNNoolviMNPolymeric micelles: basic research to clinical practiceInt J Pharm2017532124926828882486
   PubMed Web of Science ®Google Scholar
• PapiMCaputoDPalmieriVClinically approved PEGylated nanoparticles are covered by a protein corona that boosts the uptake by cancer cellsNanoscale2017929103271033428702661
   PubMed Web of Science ®Google Scholar
• MaruyamaKIntracellular targeting delivery of liposomal drugs to solid tumors based on EPR effectsAdv Drug Deliv Rev201163316116920869415
   PubMed Web of Science ®Google Scholar
• TaurinSNehoffHGreishKAnticancer nanomedicine and tumor vascular permeability; where is the missing link?J Control Release2012164326527522800576
   PubMed Web of Science ®Google Scholar
• ZouLWangDHuYDrug resistance reversal in ovarian cancer cells of paclitaxel and borneol combination therapy mediated by PEG-PAMAMOncotarget2017836604536046828947984
   PubMedGoogle Scholar